Gregory Grunberg

Gregory Grunberg is a versatile professional with a background in medicine, business, and venture capital, focusing on driving innovation in the healthcare sector. He holds a Doctor of Medicine (M.D.) from Duke University School of Medicine, an MBA from Duke University - The Fuqua School of Business, and a Bachelor of Arts (B.A.) from Amherst College.

Throughout his career, Gregory has held various roles in prestigious organizations, including serving as the Head of Life Sciences, North America, and Managing Director at Temasek. He has also contributed as a Clinical Instructor at UCSF Medical Center and held positions on the boards of companies like NOCD, On Belay Health Solutions, and Cohere Health, among others.

His extensive professional history includes leadership positions at companies such as Somatus, 89bio, and WelbeHealth. Gregory has also been actively involved in the healthcare industry through his roles at organizations like Kala Pharmaceuticals, California Cryobank LLC, and Kaiser Permanente.

With a strong educational foundation and a wide range of experience in healthcare, venture capital, and academia, Gregory Grunberg continues to make significant contributions to the field through his strategic insights and leadership.

Gregory's expertise spans across healthcare innovation, venture capital investment, board governance, and clinical practice. He brings a unique blend of medical knowledge, business acumen, and strategic thinking to the organizations he is involved with, driving growth and success in the healthcare industry.